Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
aTyr Pharma, Inc. (ATYR) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.19M |
|
$-25.74M |
|
-- |
|
$0.19M |
|
$26.93M |
|
$-26.75M |
|
$1.00M |
|
$-25.75M |
|
$-25.75M |
|
$-25.75M |
|
$-25.75M |
|
$-25.75M |
|
$-25.75M |
|
$-26.75M |
|
$-26.87M |
|
97.15M |
|
97.15M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$93.01M |
|
$4.43M |
|
$13.64M |
|
$106.65M |
|
$15.68M |
|
$0.40M |
|
$10.93M |
|
$26.61M |
|
$80.04M |
|
$80.04M |
|
$80.04M |
|
97.99M |
|
| Cash Flow Statement Financials | |
$-49.79M |
|
$-21.50M |
|
$66.14M |
|
$14.01M |
|
$8.86M |
|
$-5.14M |
|
$3.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.93 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.01 |
|
100.00% |
|
-14076.32% |
|
-14076.32% |
|
-- |
|
-13550.53% |
|
-13549.47% |
|
$-49.84M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.18 |
|
493.58 |
|
-32.16% |
|
-32.16% |
|
-24.14% |
|
-32.01% |
|
$0.82 |
|
$-0.51 |
|
$-0.51 |
|